Indaptus Therapeutics : Material Event - Form 8-K

Item 8.01. Other Events.



On May 22, 2024, Indaptus Therapeutics, Inc. announced the successful advancement of its Phase I trial investigating Decoy20.



...

Related Keywords

United States ,American , ,Indaptus Therapeutics Inc ,Safety Review Committee Of The Company ,American Society Of Clinical Oncology ,Indaptus Therapeutics ,Safety Review Committee ,American Society ,Clinical Oncology ,